[
  {
    "chunk_id": 0,
    "text": "Guideline on chronic kidney disease Bertram Kasiske, MD Mandaluyong City April 23, 2014 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org What is chronic kidney disease? When bubbles settle on the surface of the urine, they indicate disease of the kidneys, and that the complaint will be protracted. -- Hippocrates 400 BCE Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org A decade of efforts to define chronic kidney disease potassium/DOQI CPG for chronic kidney disease: Kidney Disease: Improving Global Outcomes 06 CC: Definition Kidney Disease: Improving Global Outcomes CPG on Evaluation, classification classification of chronic kidney disease. chronic kidney disease Kidney Int stratification. Am J Kidney Dis Kidney Int 2007; 72: 247 Suppl 2013; 3(1) 2002; 39: S1 Kidney Disease: Improving Global Outcomes 04 CC: Definition Kidney Disease: Improving Global Outcomes 09 CC: Definition classification of chronic kidney disease. classification of chronic kidney disease. Kidney Int 2005; 67: 2089 Kidney Int 2010; 80: 17 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Kidney Disease Outcomes Quality Initiative 2002 definition and staging Definition: Kidney damage for ≥3 months, as defined by structural or functional abnormalities of the kidney, with or without decreased glomerular filtration rate or glomerular filtration rate 60 milliliters per minute/1. 73m2 for ≥3 months, with or without kidney damage. glomerular filtration rate Stage Description (milliliters per minute/1. 73 m2) Kidney damage with 1 90 normal or glomerular filtration rate Kidney damage with 2 60-89 mild in glomerular filtration rate 3 Moderate in glomerular filtration rate 30-59 4 Severe in glomerular filtration rate 15-29 5 Kidney failure 15 (or dialysis) Am J Kidney Dis 2002; 39: S1 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Kidney Disease: Improving Global Outcomes surveys and Controversy Conferences in 2004 and 2006 Two modifications to account for dialysis and transplantation. glomerular filtration rate Stage Description Treatment (milliliters per minute/1. 73 m2) Kidney damage with 1 90 normal or glomerular filtration rate Kidney damage with 2 60-89 mild in glomerular filtration rate T if kidney transplant 3 Moderate in glomerular filtration rate 30-59 4 Severe in glomerular filtration rate 15-29 D if dialysis 5 Kidney failure 15 (or dialysis) Kidney Int 2005; 67: 2089 Kidney Int 2007; 72: 247 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org The Definition, Classification and Prognosis of chronic kidney disease: Kidney Disease: Improving Global Outcomes Controversies Conference 2009 On the basis of analyses in 45 cohorts that included 1, 555, 332 participants from general, high-risk, and chronic kidney disease populations, the conference recommended retaining the current definition for chronic kidney disease, and to modify the classification by emphasizing clinical diagnosis, adding albuminuria stage, and subdividing stage 3. Kidney Int. 2011; 80: 17 Kidney Disease: Improving Global Outcomes 6 www. Kidney Disease: Improving Global Outcomes. org Kidney Disease: Improving Global Outcomes chronic kidney disease Work Group Work Group Co-Chairs Adeera Levin Paul E Stevens Vancouver, Canada Canterbury, UK Work Group Rudy Bilous Brenda R Hemmelgarn Michael G Shlipak Middlesbrough, UK Alberta, Canada San Francisco, USA Josef Coresh Kunitoshi Iseki HaiYan Wang Bal8more, USA Nishihara, Japan Beijing, China Angel de Francisco Edmund Lamb Colin White Santander, Spain Kent, UK Vancouver, Canada Paul de Jong Andrew S Levey Christopher G Winerals Groningen, Netherlands Boston, USA Oxford, UK Kathryn Griffith Miguel C Riella York, UK Curi8ba, Brazil Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org chronic kidney disease Evidence Review Team Kidney Disease: Improving Global Outcomes www.",
    "word_count": 600,
    "char_count": 4135,
    "sentence_count": 28,
    "metadata": {
      "source_file": "KDIGO-CKD-Guideline-Manila_Kasiske.pdf",
      "extraction_date": "2025-11-21T14:29:23.369587",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2014",
      "keywords": [
        "chronic kidney disease",
        "dialysis",
        "renal",
        "albuminuria"
      ],
      "chunk_index": 0,
      "total_chunks": 7,
      "position": "1/7",
      "content_type": "recommendation",
      "content_type_confidence": 2,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "kidney failure",
        "albuminuria",
        "potassium",
        "dialysis",
        "kidney transplant",
        "stage 3",
        "guideline",
        "classification"
      ],
      "entity_count": 10
    }
  },
  {
    "chunk_id": 1,
    "text": "Kidney Disease: Improving Global Outcomes. org chronic kidney disease Evidence Review Team Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org The chronic kidney disease guideline team Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org chronic kidney disease guideline goal to clarify the definition and classification system of chronic kidney disease, and to develop appropriate guidance as to the management and care of people with chronic kidney disease foster an extended collaborative research agenda . Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org What the guideline covers Target population: all adults and children identified with chronic kidney disease who are not on renal replacement therapy. chronic kidney disease: any (or unknown) cause. Target audience: nephrologists, primary care physicians, non-nephrology specialists, clinical chemists and other practitioners caring for adults and children with chronic kidney disease. Target healthcare settings: primary, secondary and tertiary care. Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org What is not in the guideline Evaluation and management of people receiving renal replacement therapy Specific diagnostic approaches to people with acute kidney injury, glomerulonephritis or other specific diagnoses Treatment of each of the specific causes of chronic kidney disease Management of pregnancy in women with chronic kidney disease or of pregnant women who develop kidney disease Detailed management of complications of chronic kidney disease Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Quality High A Strength of 1 We recommend of recomModerate B evidence mendation Low C 2 We suggest Very low D Grade 1A Grade 2D (8 options); plus Not Graded Guyatt GH, et al. BMJ 2008; 336: 924 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Topics Section 1: Definition Classification Section 2: Definition, Identification Prediction of chronic kidney disease Progression Section 3: Management of chronic kidney disease Progression Complications Section 4: Other Complications Section 5: Referral to Specialists Models of Care Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org SECTION 1: Definition and Classification Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Audience Response Question 1: Which of the following would NOT meet the Kidney Disease: Improving Global Outcomes definition of chronic kidney disease ≥3 months of: 1. glomerular filtration rate 65 urine albumin 60 magnesium/24h 2. glomerular filtration rate 65 urine RBCs with IgA on biopsy 3. glomerular filtration rate 65 after kidney transplant 4. glomerular filtration rate 65 after donating a kidney for transplant 5. glomerular filtration rate 45 at age 75 years Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org 1. 1 Definition of chronic kidney disease 1. 1. 1: chronic kidney disease is defined as abnormalities of kidney structure or function, present for ≥3 months, with implications for health (Table 2). (Not Graded) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Audience Response Question 2: Which of the following justifies including glomerular filtration rate 60 milliliters per minute/1. 73m2 in defining chronic kidney disease: 1. increased risk for cardiovascular disease 2. increased risk of all-cause mortality 3. increased risk of drug dosing errors 4. increased risk of metabolic complications 5. all of the above Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Rationale for defining chronic kidney disease by glomerular filtration rate 60 milliliters per minute/1. 73m2 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes.",
    "word_count": 591,
    "char_count": 4200,
    "sentence_count": 39,
    "metadata": {
      "source_file": "KDIGO-CKD-Guideline-Manila_Kasiske.pdf",
      "extraction_date": "2025-11-21T14:29:23.369587",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2014",
      "keywords": [
        "chronic kidney disease",
        "dialysis",
        "renal",
        "albuminuria"
      ],
      "chunk_index": 1,
      "total_chunks": 7,
      "position": "2/7",
      "section": "Kidney Disease:",
      "content_type": "recommendation",
      "content_type_confidence": 3,
      "medical_entities": [
        "chronic kidney disease",
        "acute kidney injury",
        "glomerular filtration rate",
        "magnesium",
        "kidney transplant",
        "cardiovascular disease",
        "guideline",
        "classification"
      ],
      "entity_count": 8
    }
  },
  {
    "chunk_id": 2,
    "text": "73m2 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Rationale for defining chronic kidney disease by glomerular filtration rate 60 milliliters per minute/1. 73m2 All-Cause Mortality; estimated glomerular filtration rate Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Rationale for defining chronic kidney disease by glomerular filtration rate 60 milliliters per minute/1. 73m2 glomerular filtration rate 60 milliliters per minute/1. 73m2 is associated with a higher risk of complications of chronic kidney disease: Drug toxicity Metabolic and endocrine complications cardiovascular disease and death Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Rationale for defining chronic kidney disease by albumin-creatinine ratio 30 magnesium/g All-Cause Mortality; albumin-creatinine ratio Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org 1. 2 Staging of chronic kidney disease 1. 2. 1: We recommend that chronic kidney disease is classified based on cause, glomerular filtration rate category and albuminuria category (CGA). (1B) 1. 2. 2: Assign cause of chronic kidney disease based on presence or absence of systemic disease and the location within the kidney of observed or presumed pathologicanatomic findings. (Not graded) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org glomerular filtration rate categories 1. 2. 3: Assign glomerular filtration rate categories as follows Table 5 (Not Graded): Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Rationale for glomerular filtration rate categories AS Go, et al. New Engl J Med 2004; 351: 1296 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Title AS Levey, et al. Kidney Int 2011; 80: 17 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org AS Levey, et al. Kidney Int 2011; 80: 17 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Albuminuria categories 1. 2. 4: Assign albuminuria categories as follows (Not Graded): note that where albuminuria measurement is not available, urine reagent strip results can be substituted. Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org 1. 3 Predicting prognosis of chronic kidney disease 1. 3. 1: In predicting risk for outcome of chronic kidney disease, identify the following variables: 1) cause of chronic kidney disease; 2) glomerular filtration rate category; 3) albuminuria category; 4) other risk factors and comorbid conditions. (Not Graded) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org 1. 4 Evaluation of chronic kidney disease: chronicity 1. 4. 1: Evaluation of Chronicity 1. 4. 1. 1: In people with glomerular filtration rate 60 milliliters per minute/1. 73m2 or markers of kidney damage, review past history and previous measurements to determine duration (Not Graded). If duration is 3 months, chronic kidney disease is confirmed. Follow recommendations for chronic kidney disease. If duration is not 3 months or unclear, chronic kidney disease is not confirmed. Patients may have chronic kidney disease or acute kidney diseases (including acute kidney injury) or both and tests should be repeated accordingly. Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org 1. 4 Evaluation of chronic kidney disease: cause 1. 4. 2: Evaluation of Cause 1. 4. 2. 1: Evaluate the clinical context, including personal and family history, social and environmental factors, medications, physical examination, laboratory measures, imaging, and pathologic diagnosis to determine the causes of kidney disease. (Not Graded) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes.",
    "word_count": 596,
    "char_count": 4222,
    "sentence_count": 71,
    "metadata": {
      "source_file": "KDIGO-CKD-Guideline-Manila_Kasiske.pdf",
      "extraction_date": "2025-11-21T14:29:23.369587",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2014",
      "keywords": [
        "chronic kidney disease",
        "dialysis",
        "renal",
        "albuminuria"
      ],
      "chunk_index": 2,
      "total_chunks": 7,
      "position": "3/7",
      "content_type": "evidence",
      "content_type_confidence": 3,
      "medical_entities": [
        "chronic kidney disease",
        "acute kidney injury",
        "glomerular filtration rate",
        "albuminuria",
        "creatinine",
        "magnesium",
        "cardiovascular disease",
        "albumin-creatinine ratio"
      ],
      "entity_count": 8
    }
  },
  {
    "chunk_id": 3,
    "text": "(Not Graded) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Audience Response Question 3: Which does Kidney Disease: Improving Global Outcomes recommend for defining classifying chronic kidney disease: 1. measure glomerular filtration rate with plasma or urine clearance of an inert tracer (inulin, iohexol, etc. ) whenever possible 2. use a cystatin C rather than a creatinine formula for estimated glomerular filtration rate 3. use the chronic kidney disease-EPI formula for estimated glomerular filtration rate 4. use the best available formula for estimating glomerular filtration rate with serum creatinine Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org 1. 4 Evaluation of chronic kidney disease: glomerular filtration rate 1. 4. 3. 1: We recommend using serum creatinine and a glomerular filtration rate estimating equation for initial assessment. (1A) 1. 4. 3. 2: We suggest using additional tests (such as cystatin C or a clearance measurement) for confirmatory testing in specific circumstances when estimated glomerular filtration rate based on serum creatinine is less accurate. (2B) 1. 4. 3. 3: We recommend that clinicians (1B): use a glomerular filtration rate estimating equation to derive glomerular filtration rate from serum creatinine (estimated glomerular filtration rate ) rather than relying on the creat serum creatinine concentration alone understand clinical settings in which estimated glomerular filtration rate is less creat accurate. Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Cystatin C 1. 4. 3. 5: We suggest measuring cystatin C in adults with estimated glomerular filtration rate 45-59 who do not have other markers of creat kidney damage if confirmation of chronic kidney disease is required. (2C) If estimated glomerular filtration rate / estimated glomerular filtration rate is also 60 milliliters per minute/1. 73 m2, cys creat-cys the diagnosis of chronic kidney disease is confirmed If estimated glomerular filtration rate / estimated glomerular filtration rate is 60 milliliters per minute/1. 73 m2, the cys creat-cys diagnosis of chronic kidney disease is not confirmed Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Performance of the chronic kidney disease-EPI and MDRD study equations AS Levey, et al. Ann Intern Med 2009; 150: 604 Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Measuring glomerular filtration rate 1. 4. 3. 8: We suggest measuring glomerular filtration rate using exogenous filtration markers under circumstances where more accurate ascertainment of glomerular filtration rate will impact on treatment decisions (e. g. acceptance for kidney donation, dose adaptation of toxic drugs). (2B) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org 1. 4 Evaluation of chronic kidney disease: albuminuria 1. 4. 4. 1: We suggest using the following measurements for initial testing of proteinuria (in descending order of preference, in all cases an early morning urine sample is preferred) (2B): 1) urine albumin-to-creatinine ratio (albumin-creatinine ratio); 2) urine protein-to-creatinine ratio (protein-creatinine ratio); 3) reagent strip urinalysis for total protein with automated reading; 4) reagent strip urinalysis for total protein with manual reading. Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org 1. 4 Evaluation of chronic kidney disease: albuminuria 1. 4. 4. 2: We recommend that clinical laboratories report albumin-creatinine ratio and protein-creatinine ratio in untimed urine samples in addition to albumin concentration or proteinuria concentrations rather than the concentrations alone. (1B) 1. 4. 4. 2. 1: The term microalbuminuria should no longer be used by laboratories. (Not Graded) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org SECTION 2: Definition, Identification and Prediction of chronic kidney disease Progression Kidney Disease: Improving Global Outcomes www.",
    "word_count": 600,
    "char_count": 4220,
    "sentence_count": 57,
    "metadata": {
      "source_file": "KDIGO-CKD-Guideline-Manila_Kasiske.pdf",
      "extraction_date": "2025-11-21T14:29:23.369587",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2014",
      "keywords": [
        "chronic kidney disease",
        "dialysis",
        "renal",
        "albuminuria"
      ],
      "chunk_index": 3,
      "total_chunks": 7,
      "position": "4/7",
      "content_type": "recommendation",
      "content_type_confidence": 3,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "albuminuria",
        "proteinuria",
        "creatinine",
        "cystatin C",
        "serum creatinine",
        "albumin-creatinine ratio"
      ],
      "entity_count": 8
    }
  },
  {
    "chunk_id": 4,
    "text": "org SECTION 2: Definition, Identification and Prediction of chronic kidney disease Progression Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org 2. 1 Definition and identification of chronic kidney disease progression 2. 1. 1: Assess glomerular filtration rate and albuminuria at least annually in people with chronic kidney disease. Assess glomerular filtration rate and albuminuria more often for individuals at higher risk of progression, and/ or where measurement will impact therapeutic decisions. (Not Graded) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Guide to frequency of monitoring (number of times per year) by glomerular filtration rate and albuminuria category Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org chronic kidney disease progression 2. 1. 3: Define chronic kidney disease progression based on one of more of the following (Not Graded): Decline in glomerular filtration rate category (≥90 G1, 60-89 G2, 45-59 G3a, 30-44 G3b, 15-29 G4, 15 G5 milliliters per minute/1. 73m2). A certain drop in estimated glomerular filtration rate is defined as a drop in glomerular filtration rate category accompanied by a 25% or greater drop in estimated glomerular filtration rate from baseline. Rapid progression is defined as a sustained decline in estimated glomerular filtration rate of more than 5 mL/1. 73m2/year. The confidence in assessing progression is increased with increasing number of serum creatinine measurements and duration of follow-up. Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org SECTION 3: Management of Progression and Complications of chronic kidney disease Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Audience Response Question 4: Management of chronic kidney disease should include all BUT: 1. targeting blood pressure ≤140/90 mm Hg if no proteinuria 2. targeting blood pressure ≤130/80 mm Hg if proteinuria 3. treating hyperuricemia 4. using a statin for increased cardiovascular disease risk 5. targeting hemoglobin hemoglobin A1c (hemoglobin hemoglobin A1c) 7. 0% Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Blood Pressure 3. 1. 1: Individualize blood pressure targets and agents according to age, coexistent cardiovascular disease and other comorbidities, risk of progression of chronic kidney disease, presence or absence of retinopathy (in chronic kidney disease patients with diabetes), and tolerance of treatment as described in the Kidney Disease: Improving Global Outcomes 2012 Blood Pressure Guideline. (Not Graded). See Kidney Disease: Improving Global Outcomes Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int Suppl December 2012; Vol. 2 (5) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Blood Pressure 3. 1. 4: We recommend that in both diabetic and nondiabetic adults with chronic kidney disease and urine albumin excretion 30 magnesium/24 hours (or equivalent) whose office blood pressure is consistently 140 mm Hg systolic or 90 mm Hg diastolic be treated with blood pressure-lowering drugs to maintain a blood pressure that is consistently ≤140 mm Hg systolic and ≤90mm Hg diastolic. (1B) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Blood Pressure 3. 1. 5: We suggest that in both diabetic and non-diabetic adults with chronic kidney disease and with urine albumin excretion of ≥30 magnesium/24 hours (or equivalent) whose office blood pressure is consistently 130 mm Hg systolic or 80 mm Hg diastolic be treated with blood pressure-lowering drugs to maintain a blood pressure that is consistently ≤130 mm Hg systolic and ≤80 mm Hg diastolic. (2D) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Blood Pressure 3. 1.",
    "word_count": 590,
    "char_count": 4056,
    "sentence_count": 46,
    "metadata": {
      "source_file": "KDIGO-CKD-Guideline-Manila_Kasiske.pdf",
      "extraction_date": "2025-11-21T14:29:23.369587",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2014",
      "keywords": [
        "chronic kidney disease",
        "dialysis",
        "renal",
        "albuminuria"
      ],
      "chunk_index": 4,
      "total_chunks": 7,
      "position": "5/7",
      "content_type": "recommendation",
      "content_type_confidence": 4,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "albuminuria",
        "proteinuria",
        "creatinine",
        "magnesium",
        "hemoglobin",
        "serum creatinine",
        "cardiovascular disease",
        "retinopathy"
      ],
      "entity_count": 10
    }
  },
  {
    "chunk_id": 5,
    "text": "(2D) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Blood Pressure 3. 1. 6: We suggest that an angiotensin receptor blocker or angiotensin-converting enzyme inhibitor be used in diabetic adults with chronic kidney disease and urine albumin excretion 30-300 magnesium/24 hours (or equivalent). (2D) 3. 1. 7: We recommend that an angiotensin receptor blocker or angiotensin-converting enzyme inhibitor be used in both diabetic and non-diabetic adults with chronic kidney disease and urine albumin excretion 300 magnesium/24 hours (or equivalent). (1B) 3. 1. 8: There is insufficient evidence to recommend combining an angiotensin-converting enzyme inhibitor with ARBs to prevent progression of chronic kidney disease. (Not Graded) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org CDK Risk of AK I 3. 1. 12: We recommend that all people with chronic kidney disease are considered to be at increased risk of acute kidney injury. (1A) 3. 1. 12. 1: In people with chronic kidney disease the recommendations detailed in the Kidney Disease: Improving Global Outcomes acute kidney injury Guideline should be followed for management of those at risk of acute kidney injury during inter-current illness, or when undergoing investigation and procedures that are likely to increase the risk of acute kidney injury. (Not Graded) See Kidney Disease: Improving Global Outcomes Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl March 2012; Vol. 2 (1) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Protein Intake 3. 1. 13: We suggest lowering protein intake to 0. 8 g/kg/day in adults with diabetes (2C) or without diabetes (2B) and glomerular filtration rate 30 milliliters per minute/1. 73m2 (glomerular filtration rate categories G4G5), with appropriate education. 3. 1. 14: We suggest avoiding high protein intake (1. 3 g/ kg/day) in adults with chronic kidney disease at risk of progression. (2C) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Glycemic Control 3. 1. 15: We recommend a target hemoglobin hemoglobin A1c (hemoglobin hemoglobin A1c) of 7. 0% (53 mmol/mol) to prevent or delay progression of the microvascular complications of diabetes, including diabetic kidney disease. (1A) 3. 1. 16: We recommend not treating to an hemoglobin hemoglobin A1c target of 7. 0% (53 mmol/mol) in patients at risk of hypoglycemia. (1B) 3. 1. 17: We suggest that target hemoglobin hemoglobin A1c be extended above 7. 0% (53 mmol/mol) in individuals with comorbidities or limited life expectancy and risk of hypoglycemia. (2C) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Salt Intake 3. 1. 12: We recommend lowering salt intake to 90 mmol (2 g) per day of sodium (corresponding to 5 g of sodium chloride) in adults, unless contraindicated. (1C) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Hyperuricemia 3. 1. 13: There is insufficient evidence to support or refute the use of agents to lower serum uric acid concentrations in people with chronic kidney disease and either symptomatic or asymptomatic hyperuricemia in order to delay progression of chronic kidney disease. (Not Graded) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Lifestyle 3. 1. 14: We recommend that people with chronic kidney disease be encouraged to take exercise (aiming for at least 30 minutes 5 times per week), achieve a healthy weight (body mass index 20-25, according to country specific demographics), and stop smoking. (1D) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Anemia 3. 2.",
    "word_count": 580,
    "char_count": 3841,
    "sentence_count": 66,
    "metadata": {
      "source_file": "KDIGO-CKD-Guideline-Manila_Kasiske.pdf",
      "extraction_date": "2025-11-21T14:29:23.369587",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2014",
      "keywords": [
        "chronic kidney disease",
        "dialysis",
        "renal",
        "albuminuria"
      ],
      "chunk_index": 5,
      "total_chunks": 7,
      "position": "6/7",
      "content_type": "recommendation",
      "content_type_confidence": 4,
      "medical_entities": [
        "chronic kidney disease",
        "acute kidney injury",
        "glomerular filtration rate",
        "sodium",
        "magnesium",
        "chloride",
        "uric acid",
        "hemoglobin",
        "ARBs",
        "anemia"
      ],
      "entity_count": 10
    }
  },
  {
    "chunk_id": 6,
    "text": "(1D) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Anemia 3. 2. 3: To identify anemia in people with chronic kidney disease measure hemoglobin concentration (Not Graded): when clinically indicated in people with glomerular filtration rate ≥60 milliliters per minute/1. 73 m2 (glomerular filtration rate categories G1-G2); at least annually in people with glomerular filtration rate 30-59 ml/ min/1. 73 m2 (glomerular filtration rate categories G3a-G3b); at least twice per year in people with glomerular filtration rate 30 milliliters per minute/1. 73 m2 (glomerular filtration rate categories G4-G5). See Kidney Disease: Improving Global Outcomes Clinical Practice Guideline for Anemia in chronic kidney disease. Kidney Int Suppl August 2012; Vol. 2(4) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Chronic Kidney Disease-Mineral and Bone Disorder (chronic kidney disease-mineral and bone disorder) 3. 3. 1: We recommend measuring serum levels of calcium, phosphate, parathyroid hormone, and alkaline phosphatase activity at least once in adults with glomerular filtration rate 45 milliliters per minute/ 1. 73 m2 (glomerular filtration rate categories G3b-G5) in order to determine baseline values and inform prediction equations if used. (1C) See Kidney Disease: Improving Global Outcomes Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of chronic kidney disease-mineral and bone disorder 2009. Kidney Int August 2009; Vol. 76 (Suppl 113) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Acidosis 3. 4. 1: We suggest that in people with chronic kidney disease and serum bicarbonate concentrations 22 millimoles per liter treatment with oral bicarbonate supplementation be given to maintain serum bicarbonate within the normal range, unless contraindicated. (2B) Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org SECTION 4: Other Complications of chronic kidney disease Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Other Complications of chronic kidney disease Cardiac and vascular disease (cardiovascular disease) Medication dosage Patient safety Infections Hospitalizations Caveats for investigating complications Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org SECTION 5: Referral to Specialists and Models of Care Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Title When to refer to a spcialist. Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Summary: Key Changes Diagnosis and classification: Re-emphasise need for a diagnosis Add albuminuria categories Subdivide glomerular filtration rate category 3 Define progression preventive measures Interpretation of tests use of medications Models of care Kidney Disease: Improving Global Outcomes www. Kidney Disease: Improving Global Outcomes. org Thank you! www. Kidney Disease: Improving Global Outcomes. org",
    "word_count": 432,
    "char_count": 3174,
    "sentence_count": 40,
    "metadata": {
      "source_file": "KDIGO-CKD-Guideline-Manila_Kasiske.pdf",
      "extraction_date": "2025-11-21T14:29:23.369587",
      "document_type": "medical_guideline",
      "language": "en",
      "year": "2014",
      "keywords": [
        "chronic kidney disease",
        "dialysis",
        "renal",
        "albuminuria"
      ],
      "chunk_index": 6,
      "total_chunks": 7,
      "position": "7/7",
      "content_type": "treatment",
      "content_type_confidence": 4,
      "medical_entities": [
        "chronic kidney disease",
        "glomerular filtration rate",
        "albuminuria",
        "calcium",
        "phosphate",
        "bicarbonate",
        "hemoglobin",
        "parathyroid hormone",
        "anemia",
        "acidosis"
      ],
      "entity_count": 10
    }
  }
]